85 related articles for article (PubMed ID: 10379937)
1. Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep.
Kabeya H; Ohashi K; Sugimoto C; Onuma M
J Vet Med Sci; 1999 May; 61(5):475-80. PubMed ID: 10379937
[TBL] [Abstract][Full Text] [Related]
2. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
Gatei MH; Good MF; Daniel RC; Lavin MF
J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
[TBL] [Abstract][Full Text] [Related]
3. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
4. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
5. Novel CD8(+) cytotoxic T cell epitopes in bovine leukemia virus with cattle.
Bai L; Takeshima SN; Isogai E; Kohara J; Aida Y
Vaccine; 2015 Dec; 33(51):7194-7202. PubMed ID: 26552001
[TBL] [Abstract][Full Text] [Related]
6. The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection.
Konnai S; Takeshima SN; Tajima S; Yin SA; Okada K; Onuma M; Aida Y
Microbiol Immunol; 2003; 47(3):223-32. PubMed ID: 12725293
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.
Kabeya H; Ohashi K; Oyunbileg N; Nagaoka Y; Aida Y; Sugimoto C; Yokomizo Y; Onuma M
Vet Immunol Immunopathol; 1999 May; 68(2-4):255-65. PubMed ID: 10438324
[TBL] [Abstract][Full Text] [Related]
8. T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values.
Mager A; Masengo R; Mammerickx M; Letesson JJ
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2223-31. PubMed ID: 7521391
[TBL] [Abstract][Full Text] [Related]
9. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the regulatory T cell-associated marker CTLA-4 in bovine leukemia virus infection.
Suzuki S; Konnai S; Okagawa T; Ikebuchi R; Nishimori A; Kohara J; Mingala CN; Murata S; Ohashi K
Vet Immunol Immunopathol; 2015 Feb; 163(3-4):115-24. PubMed ID: 25618590
[TBL] [Abstract][Full Text] [Related]
11. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
[TBL] [Abstract][Full Text] [Related]
12. gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.
Lundberg P; Splitter GA
J Virol; 2000 Sep; 74(18):8299-306. PubMed ID: 10954528
[TBL] [Abstract][Full Text] [Related]
13. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
[TBL] [Abstract][Full Text] [Related]
14. Delayed-type hypersensitivity in sheep induced by synthetic peptides of bovine leukemia virus encapsulated in mannan-coated liposome.
Okada K; Sonoda K; Koyama M; Yin S; Ikeda M; Goryo M; Chen SL; Kabeya H; Ohishi K; Onuma M
J Vet Med Sci; 2003 Apr; 65(4):515-8. PubMed ID: 12736435
[TBL] [Abstract][Full Text] [Related]
15. Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1143-8. PubMed ID: 8911011
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.
Johnston ER; Powers MA; Kidd LC; Radke K
J Virol; 1996 Sep; 70(9):6296-303. PubMed ID: 8709257
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.
Pyeon D; Diaz FJ; Splitter GA
J Virol; 2000 Jun; 74(12):5740-5. PubMed ID: 10823885
[TBL] [Abstract][Full Text] [Related]
18. Recombinant viral vaccines for enzootic bovine leucosis.
Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
20. CD4 T lymphocyte activation in BLV-induced persistent B lymphocytosis in cattle.
Stone DM; Norton LK; Chambers JC; Meek WJ
Clin Immunol; 2000 Sep; 96(3):280-8. PubMed ID: 10964547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
